Tezepelumab

• CAT Number: I042226
• CAS Number: 1572943-04-4
• Purity: ≥95%

Tezepelumab（Cat No.:I042226）is a monoclonal antibody that targets and inhibits thymic stromal lymphopoietin (TSLP), a key cytokine involved in the inflammatory response. TSLP plays a crucial role in the pathogenesis of various allergic and inflammatory diseases, including asthma and atopic dermatitis. By blocking TSLP, Tezepelumab helps reduce airway inflammation and immune system activation. It has been studied for the treatment of severe asthma and other allergic conditions, with clinical trials demonstrating its potential to improve symptoms and reduce exacerbations. Tezepelumab offers a targeted approach to managing conditions driven by inflammation and immune dysregulation.